Therefore, seronegative RA is a heterogeneous group and further studies are needed to understand if there indeed is an autoimmunity component, presumably distinct from ACPA+ RA, present in a subset or a larger proportion of these patients. This evidence concerns the gene PRTN3 and rheumatoid arthritis.